Sign in

CIK 0001339970

  • Non-accelerated filer
  • Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203435077
Phone
+1 858-731-8389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 245,000 shares at an average $0.42 ($103,247)
  4. 4 Open-market buy Director bought 147,225 shares at $0.54 ($79,796)
  5. 4 Open-market buy Chief Financial Officer bought 64,000 shares at an average $0.83 ($52,855)
  6. 4 Open-market buy Chief Financial Officer bought 26,000 shares at $0.73 ($19,055)
  7. 4 Open-market buy Director bought 42,749 shares at an average $0.74 ($31,461)
  8. 4 Open-market buy Director bought 164,411 shares at an average $0.74 ($121,573)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Option exercise See Remarks acquired 3,333 shares (option exercise)
  12. 4 Open-market buy Director bought 150,000 shares at $1.00 ($149,445)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale 10% owner sold 3,209,316 shares at an average $0.93 ($2,999,056)

Page 8 of 17 · 329 filings